MedTech M&A-Report Q3 2024
Strategic perspectives on the M&A landscape of the MedTech industry
Further increase in domestic M&A activities
In our latest MedTech M&A Report Q3 2024, we highlight the M&A trends in the MedTech sector at both global and Swiss level.
Multiples remain high and are above the long-term median, which makes the market attractive for sellers. Strategists are again increasingly acting as buyers of MedTech companies and are primarily coming from America, followed by Europe. Cross-border transactions are therefore a decisive element in the MedTech M&A market.
Please do not hesitate to contact our experts, who will be happy to discuss further points of interest or questions on the topic with you and show you how Oaklins can add value with its close international network of contacts. We are at your disposal to discuss your specific M&A and corporate finance needs.
Your contact persons
Partner
View profile
Partner
View profile
Completed M&A transactions in the healthcare sector